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Abstract
The prevalence of HIV-1 integrase mutations related to resistance to the next-generation integrase inhibitor (INI), dolutegravir (DTG),
was assessed in 440 INI-naı¨ve subjects and in 120 patients failing a raltegravir (RTG)-containing regimen. Of the mutations selected by
DTG in vitro, S153FY was not detected in any isolate while L101I and T124A were highly prevalent in both groups and signiﬁcantly asso-
ciated with non-B subtype. RTG-selected double and triple mutants, mostly the G140S/Q148H variant, were detected in only 32 (26.7%)
RTG-treated patients. As L101I and T124A do not appear to exert any major effect in vivo and double and triple mutants resistant to DTG
are infrequently selected by RTG, DTG can be effectively used in INI-naı¨ve patients and may retain activity in many patients failing RTG.
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Abstract
We report a case of viral peritonitis caused by coxsackievirus B1 in a 79-year-old male undergoing continuous ambulatory peritoneal
dialysis (CAPD), and review the English language literature. Clinicians should be aware of viral peritonitis in patients on CAPD present-
ing with a viral syndrome and mononuclear peritoneal dialysis efﬂuent. Currently, viral diagnostic tests are available to conﬁrm the diag-
nosis and avoid unnecessary treatment with antibiotics.
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Abstract
Puumala virus infection causes epidemic nephropathia (NE), a certain type of haemorrhagic fever with renal syndrome (HFRS). Myopic
shift is considered a pathognomonic sign of NE and HFRS but rates of ocular involvement vary. The aim of the study was to evaluate
whether clinical and laboratory ﬁndings are associated with ophthalmic involvement in NE in Austria. We found that blurred vision and
myopic shift are frequent in Puumala virus infections in Austria but are independent of disease severity.
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